CANADA LIFE ASSURANCE Co Has $36.16 Million Stake in Xylem Inc. (NYSE:XYL)

CANADA LIFE ASSURANCE Co decreased its holdings in Xylem Inc. (NYSE:XYL) by 4.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 279,580 shares of the industrial products company’s stock after selling 13,155 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings in Xylem were worth $36,163,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of XYL. FinTrust Capital Advisors LLC raised its position in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after buying an additional 200 shares in the last quarter. Hazlett Burt & Watson Inc. increased its position in Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after purchasing an additional 220 shares in the last quarter. Spire Wealth Management increased its position in Xylem by 370.9% during the 4th quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock worth $54,000 after purchasing an additional 382 shares in the last quarter. Advantage Trust Co acquired a new position in Xylem during the 4th quarter worth approximately $57,000. Finally, Gradient Investments LLC increased its position in Xylem by 28.6% during the 4th quarter. Gradient Investments LLC now owns 576 shares of the industrial products company’s stock worth $66,000 after purchasing an additional 128 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Up 1.6 %

NYSE:XYL traded up $2.17 during trading hours on Thursday, hitting $138.88. The company had a trading volume of 550,352 shares, compared to its average volume of 1,191,971. The company has a market capitalization of $33.67 billion, a PE ratio of 48.64, a price-to-earnings-growth ratio of 2.50 and a beta of 1.04. The stock has a 50-day moving average price of $138.71 and a 200 day moving average price of $130.03. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $146.08. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.67 and a quick ratio of 1.22.

Xylem (NYSE:XYL) last released its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The firm’s revenue for the quarter was up 40.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.72 earnings per share. On average, equities research analysts predict that Xylem Inc. will post 4.22 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 27th. Investors of record on Thursday, May 30th were paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend was Thursday, May 30th. Xylem’s payout ratio is 51.25%.

Insider Buying and Selling

In related news, SVP Rodney Aulick sold 21,800 shares of the company’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the transaction, the senior vice president now owns 76,287 shares in the company, valued at approximately $10,604,655.87. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the transaction, the chief accounting officer now owns 3,536 shares in the company, valued at approximately $490,195.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the transaction, the senior vice president now owns 76,287 shares in the company, valued at approximately $10,604,655.87. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on XYL shares. Mizuho boosted their target price on shares of Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a report on Friday, May 3rd. Royal Bank of Canada increased their target price on shares of Xylem from $157.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. Robert W. Baird upped their price objective on shares of Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. TD Cowen upped their price objective on shares of Xylem from $135.00 to $138.00 and gave the stock a “buy” rating in a report on Thursday, June 6th. Finally, Citigroup upped their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Five analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and a consensus price target of $144.58.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.